AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+123.6%
5Y CAGR+76.0%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+123.6%/yr
vs +27.3%/yr prior
5Y CAGR
+76.0%/yr
Recent acceleration
Acceleration
+96.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
16.9x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$3.53B+23.6%
2024$2.86B+95.9%
2023$1.46B+361.7%
2022$316.00M+41.3%
2021$223.70M+7.0%
2020$209.10M+51.7%
2019$137.80M+14.6%
2018$120.20M-25.6%
2017$161.50M+55.7%
2016$103.70M-